Skip to main content
logo
Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.410
-0.020 (-0.45%)
Sep 8, 2026, 11:10 AM EDT - Market open

Minerva Neurosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
----12.71--
Operating Income
-28.54-15.1-21.85-23.12-25.23-30.17
Net Income
-394.35-293.421.44-30.01-32.11-49.91
Earnings Per Share
-14.44-34.670.19-4.61-6.01-9.35
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
75.2782.321.3640.9136.0960.76
Total Debt
60606082.0273.7366.33
Net Cash (Debt)
15.2722.3-38.64-41.1-37.64-5.57
Net Cash Growth
------
Net Cash Per Share
0.562.64-5.10-6.32-7.05-1.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.17-13.51-19.55-14.78-24.65-24.6
Capital Expenditures
-----0.02-
Free Cash Flow
-26.17-13.51-19.55-14.78-24.66-24.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--10.80---
PS Ratio
------